Bacher, Ulrike; Shumilov, Evgenii; Pabst, Thomas (2023). Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies. British journal of haematology, 202(6), pp. 1081-1083. Wiley-Blackwell 10.1111/bjh.19005
|
Text
Br_J_Haematol_-_2023_-_Bacher.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (198kB) | Preview |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory |
UniBE Contributor: |
Bacher, Vera Ulrike, Pabst, Thomas Niklaus |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0007-1048 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
02 Aug 2023 12:11 |
Last Modified: |
13 Sep 2023 00:15 |
Publisher DOI: |
10.1111/bjh.19005 |
PubMed ID: |
37519052 |
Uncontrolled Keywords: |
B-cell depletion B-cell malignancies COVID-19 vaccine |
BORIS DOI: |
10.48350/185157 |
URI: |
https://boris.unibe.ch/id/eprint/185157 |
Actions (login required)
 |
Edit item |